FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029597938> ?p ?o ?g. }

• W2029597938 endingPage "210" @default.
• W2029597938 startingPage "201" @default.
• W2029597938 abstract "In recent years, attention has been focused on the anti-cancer properties of pure components, an important role in the prevention of disease. Andrographolide (Andro), the major constituent of Andrographis paniculata (Burm. F.) Nees plant, is implicated towards its pharmacological activity. To investigate the mechanism basis for the anti-tumor properties of Andro, Andro was used to examine its effect on cell-cycle progression in human colorectal carcinoma Lovo cells. The data from cell growth experiment showed that Andro exhibited the anti-proliferation effect on Lovo cells in a time- and dose-dependent manner. This event was accompanied the arrest of the cells at the G1–S phase by Andro at the tested concentrations of 0–30 μM. Cellular uptake of Andro and Andro was confirmed by capillary electrophoresis analysis and the intracellular accumulation of Andro (0.61 ± 0.07 μM/mg protein) was observed when treatment of Lovo cells with Andro for 12 h. In addition, an accumulation of the cells in G1 phase (15% increase for 10 μM of Andro) was observed as well as by the association with a marked decrease in the protein expression of Cyclin A, Cyclin D1, Cdk2 and Cdk4. Andro also inducted the content of Cdk inhibitor p21 and p16, and the phosphorylation of p53. Further immunoprecipitation studies found that, in response to the treatment, the formation of Cyclin D1/Cdk4 and Cyclin A/Cdk2 complexes had declined, preventing the phosphorylation of Rb and the subsequent dissociation of Rb/E2F complex. These results suggested Andro can inhibit Lovo cell growth by G1–S phase arrest, and was exerted by inducing the expression of p53, p21 and p16 that, in turn, repressed the activity of Cyclin D1/Cdk4 and/or Cyclin A/Cdk2, as well as Rb phosphorylation." @default.
• W2029597938 created "2016-06-24" @default.
• W2029597938 creator A5003018141 @default.
• W2029597938 creator A5015556010 @default.
• W2029597938 creator A5034037962 @default.
• W2029597938 creator A5038434041 @default.
• W2029597938 creator A5047585561 @default.
• W2029597938 creator A5082215655 @default.
• W2029597938 date "2008-08-01" @default.
• W2029597938 modified "2023-09-27" @default.
• W2029597938 title "Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide" @default.
• W2029597938 cites W1491294744 @default.
• W2029597938 cites W1551309927 @default.
• W2029597938 cites W1709607181 @default.
• W2029597938 cites W1935990934 @default.
• W2029597938 cites W1966360957 @default.
• W2029597938 cites W1967020486 @default.
• W2029597938 cites W1967880683 @default.
• W2029597938 cites W1969910813 @default.
• W2029597938 cites W1972566887 @default.
• W2029597938 cites W1974391793 @default.
• W2029597938 cites W1975794635 @default.
• W2029597938 cites W1980537841 @default.
• W2029597938 cites W1992480863 @default.
• W2029597938 cites W1994245797 @default.
• W2029597938 cites W1999330214 @default.
• W2029597938 cites W2002132520 @default.
• W2029597938 cites W2005404897 @default.
• W2029597938 cites W2010991568 @default.
• W2029597938 cites W2013873169 @default.
• W2029597938 cites W2017516341 @default.
• W2029597938 cites W2018668167 @default.
• W2029597938 cites W2018702059 @default.
• W2029597938 cites W2022622460 @default.
• W2029597938 cites W2031345071 @default.
• W2029597938 cites W2034485827 @default.
• W2029597938 cites W2042471363 @default.
• W2029597938 cites W2045525616 @default.
• W2029597938 cites W2048672429 @default.
• W2029597938 cites W2064623085 @default.
• W2029597938 cites W2068084252 @default.
• W2029597938 cites W2070454827 @default.
• W2029597938 cites W2078427351 @default.
• W2029597938 cites W2087351770 @default.
• W2029597938 cites W2088455943 @default.
• W2029597938 cites W2092357174 @default.
• W2029597938 cites W2145485145 @default.
• W2029597938 cites W2149373223 @default.
• W2029597938 cites W2149724396 @default.
• W2029597938 cites W2152735757 @default.
• W2029597938 cites W2159455652 @default.
• W2029597938 cites W2169979796 @default.
• W2029597938 doi "https://doi.org/10.1016/j.cbi.2008.06.006" @default.
• W2029597938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18619950" @default.
• W2029597938 hasPublicationYear "2008" @default.
• W2029597938 type Work @default.
• W2029597938 sameAs 2029597938 @default.
• W2029597938 citedByCount "100" @default.
• W2029597938 countsByYear W20295979382012 @default.
• W2029597938 countsByYear W20295979382013 @default.
• W2029597938 countsByYear W20295979382014 @default.
• W2029597938 countsByYear W20295979382015 @default.
• W2029597938 countsByYear W20295979382016 @default.
• W2029597938 countsByYear W20295979382017 @default.
• W2029597938 countsByYear W20295979382018 @default.
• W2029597938 countsByYear W20295979382019 @default.
• W2029597938 countsByYear W20295979382020 @default.
• W2029597938 countsByYear W20295979382021 @default.
• W2029597938 countsByYear W20295979382022 @default.
• W2029597938 countsByYear W20295979382023 @default.
• W2029597938 crossrefType "journal-article" @default.
• W2029597938 hasAuthorship W2029597938A5003018141 @default.
• W2029597938 hasAuthorship W2029597938A5015556010 @default.
• W2029597938 hasAuthorship W2029597938A5034037962 @default.
• W2029597938 hasAuthorship W2029597938A5038434041 @default.
• W2029597938 hasAuthorship W2029597938A5047585561 @default.
• W2029597938 hasAuthorship W2029597938A5082215655 @default.
• W2029597938 hasConcept C124320809 @default.
• W2029597938 hasConcept C1491633281 @default.
• W2029597938 hasConcept C185592680 @default.
• W2029597938 hasConcept C199835354 @default.
• W2029597938 hasConcept C2778298596 @default.
• W2029597938 hasConcept C2781357234 @default.
• W2029597938 hasConcept C29537977 @default.
• W2029597938 hasConcept C502942594 @default.
• W2029597938 hasConcept C55493867 @default.
• W2029597938 hasConcept C62112901 @default.
• W2029597938 hasConcept C79879829 @default.
• W2029597938 hasConcept C82495950 @default.
• W2029597938 hasConcept C86803240 @default.
• W2029597938 hasConcept C94561458 @default.
• W2029597938 hasConceptScore W2029597938C124320809 @default.
• W2029597938 hasConceptScore W2029597938C1491633281 @default.
• W2029597938 hasConceptScore W2029597938C185592680 @default.
• W2029597938 hasConceptScore W2029597938C199835354 @default.
• W2029597938 hasConceptScore W2029597938C2778298596 @default.
• W2029597938 hasConceptScore W2029597938C2781357234 @default.
• W2029597938 hasConceptScore W2029597938C29537977 @default.

• next